id	sid	eid	entity	type
gsrj-11	1	1	maria victoria dias	PERSON
gsrj-11	1	2	bridgitte isom	PERSON
gsrj-11	1	3	katherine poole	ORG
gsrj-11	1	4	sofia triplett	PERSON
gsrj-11	1	5	nadia sadanandan	GPE
gsrj-11	1	6	one	CARDINAL
gsrj-11	1	7	2021	CARDINAL
gsrj-11	1	8	georgetown scientific research	ORG
gsrj-11	1	9	84	CARDINAL
gsrj-11	1	10	georgetown scientific research	ORG
gsrj-11	1	11	maria victoria dias	PERSON
gsrj-11	1	12	bridgitte isom	PERSON
gsrj-11	1	13	katherine poole	ORG
gsrj-11	1	14	sofia triplett	PERSON
gsrj-11	1	15	nadia sadanandan school	ORG
gsrj-11	1	16	georgetown university	ORG
gsrj-11	1	17	washington dc	GPE
gsrj-11	1	18	united states e	GPE
gsrj-11	1	19	nas146@georgetown.edu	ORG
gsrj-11	1	20	md1694@georgetown.edu	GPE
gsrj-11	1	21	30%	PERCENT
gsrj-11	4	1	five	CARDINAL
gsrj-11	4	2	glasdegib	ORG
gsrj-11	4	3	gant-61	DATE
gsrj-11	10	1	glasdegib	ORG
gsrj-11	10	2	gant-61	DATE
gsrj-11	10	3	85	CARDINAL
gsrj-11	10	4	georgetown scientific research	ORG
gsrj-11	10	5	1	CARDINAL
gsrj-11	10	6	first	ORDINAL
gsrj-11	10	7	harvey cushing	PERSON
gsrj-11	10	8	percival bailey	PERSON
gsrj-11	10	9	1925	DATE
gsrj-11	11	1	about 20%	PERCENT
gsrj-11	11	2	0.4 to 1%	PERCENT
gsrj-11	11	3	age 16	DATE
gsrj-11	11	4	age 40	DATE
gsrj-11	12	1	the united states	GPE
gsrj-11	12	2	500	CARDINAL
gsrj-11	12	3	200	CARDINAL
gsrj-11	12	4	every year	DATE
gsrj-11	14	1	the world health organization classified medulloblastoma	ORG
gsrj-11	14	2	four	CARDINAL
gsrj-11	14	3	3	CARDINAL
gsrj-11	14	4	4	CARDINAL
gsrj-11	15	1	30%	PERCENT
gsrj-11	15	2	3 years of age	DATE
gsrj-11	15	3	17 years	DATE
gsrj-11	15	4	the 1930s	DATE
gsrj-11	16	1	30%.5	CARDINAL
gsrj-11	16	2	1953	DATE
gsrj-11	16	3	3-year	DATE
gsrj-11	16	4	65%	PERCENT
gsrj-11	17	1	the 1970s	DATE
gsrj-11	17	2	today	DATE
gsrj-11	18	1	over 25%	PERCENT
gsrj-11	19	1	four	CARDINAL
gsrj-11	22	1	gcs	ORG
gsrj-11	23	1	cerebellar gcs	ORG
gsrj-11	23	2	tumorigenesis.8	ORG
gsrj-11	25	1	five	CARDINAL
gsrj-11	25	2	glasdegib	ORG
gsrj-11	25	3	gant-61	DATE
gsrj-11	27	1	86	CARDINAL
gsrj-11	27	2	georgetown scientific research	ORG
gsrj-11	29	1	2	CARDINAL
gsrj-11	31	1	1	CARDINAL
gsrj-11	33	1	1	CARDINAL
gsrj-11	33	2	12	CARDINAL
gsrj-11	34	1	1	CARDINAL
gsrj-11	34	2	ptch1	PERSON
gsrj-11	35	1	gli3	PERSON
gsrj-11	36	1	ptchi1	PERSON
gsrj-11	38	1	1	CARDINAL
gsrj-11	41	1	gli	ORG
gsrj-11	42	1	3	CARDINAL
gsrj-11	42	2	vismodegib	PERSON
gsrj-11	42	3	glasdegib	ORG
gsrj-11	42	4	gant-61	DATE
gsrj-11	43	1	2	CARDINAL
gsrj-11	45	1	5h8	CARDINAL
gsrj-11	45	2	87	CARDINAL
gsrj-11	45	3	2	CARDINAL
gsrj-11	46	1	ptch1	ORG
gsrj-11	46	2	glasdegib	ORG
gsrj-11	47	1	gant-61	DATE
gsrj-11	48	1	2012	DATE
gsrj-11	48	2	2015	DATE
gsrj-11	49	1	glasdegib	PERSON
gsrj-11	49	2	2018	DATE
gsrj-11	52	1	vismodegib	PERSON
gsrj-11	52	2	gdc-0449	DATE
gsrj-11	55	1	12.5 mg/kg	QUANTITY
gsrj-11	55	2	540 mg	QUANTITY
gsrj-11	55	3	3 months	DATE
gsrj-11	56	1	sonidegib	PERSON
gsrj-11	58	1	5 mg/kg	QUANTITY
gsrj-11	60	1	glasdegib	ORG
gsrj-11	61	1	fda	ORG
gsrj-11	62	1	16-21	CARDINAL
gsrj-11	62	2	2007 to 2008	DATE
gsrj-11	62	3	68	CARDINAL
gsrj-11	63	1	one	CARDINAL
gsrj-11	67	1	since 2008	DATE
gsrj-11	67	2	2013	DATE
gsrj-11	68	1	6	CARDINAL
gsrj-11	68	2	85 mg/m2	QUANTITY
gsrj-11	68	3	7	CARDINAL
gsrj-11	68	4	170mg/m2	PRODUCT
gsrj-11	69	1	88	CARDINAL
gsrj-11	72	1	three	CARDINAL
gsrj-11	72	2	seven	CARDINAL
gsrj-11	72	3	first	ORDINAL
gsrj-11	73	1	1	CARDINAL
gsrj-11	74	1	2	CARDINAL
gsrj-11	74	2	2015	DATE
gsrj-11	74	3	31	CARDINAL
gsrj-11	74	4	12	CARDINAL
gsrj-11	74	5	150-300 mg	QUANTITY
gsrj-11	76	1	8 weeks	DATE
gsrj-11	77	1	30%	PERCENT
gsrj-11	78	1	3	CARDINAL
gsrj-11	78	2	1	CARDINAL
gsrj-11	79	1	41%	PERCENT
gsrj-11	84	1	21	DATE
gsrj-11	84	2	2014	DATE
gsrj-11	84	3	bcc	ORG
gsrj-11	85	1	3/4	CARDINAL
gsrj-11	85	2	18%	PERCENT
gsrj-11	87	1	2017 phase ii	QUANTITY
gsrj-11	87	2	60	CARDINAL
gsrj-11	87	3	16	CARDINAL
gsrj-11	88	1	daily	DATE
gsrj-11	89	1	39	DATE
gsrj-11	90	1	5	CARDINAL
gsrj-11	91	1	2	CARDINAL
gsrj-11	91	2	2	CARDINAL
gsrj-11	92	1	one	CARDINAL
gsrj-11	93	1	50	CARDINAL
gsrj-11	93	2	tumor.21	CARDINAL
gsrj-11	98	1	89	CARDINAL
gsrj-11	99	1	150 mg	QUANTITY
gsrj-11	103	1	gant-61	DATE
gsrj-11	105	1	daoy	PERSON
gsrj-11	106	1	gant-61	DATE
gsrj-11	106	2	cisplatin	PERSON
gsrj-11	107	1	4	CARDINAL
gsrj-11	108	1	25	CARDINAL
gsrj-11	108	2	three	CARDINAL
gsrj-11	110	1	two	CARDINAL
gsrj-11	112	1	4.1	CARDINAL
gsrj-11	116	1	33%	PERCENT
gsrj-11	117	1	2016	CARDINAL
gsrj-11	117	2	gant-61	DATE
gsrj-11	119	1	gant-61	DATE
gsrj-11	119	2	doay	GPE
gsrj-11	119	3	gant61	ORG
gsrj-11	120	1	gant-61	DATE
gsrj-11	121	1	90	CARDINAL
gsrj-11	121	2	georgetown scientific research	ORG
gsrj-11	123	1	gli2	PERSON
gsrj-11	124	1	gli2	PERSON
gsrj-11	124	2	19	CARDINAL
gsrj-11	124	3	26	CARDINAL
gsrj-11	124	4	one	CARDINAL
gsrj-11	124	5	inhibitors.19	ORG
gsrj-11	124	6	26	CARDINAL
gsrj-11	124	7	26	CARDINAL
gsrj-11	124	8	26	DATE
gsrj-11	124	9	27	CARDINAL
gsrj-11	125	1	28-30	CARDINAL
gsrj-11	126	1	gli2	PERSON
gsrj-11	126	2	one	CARDINAL
gsrj-11	126	3	gli1	ORG
gsrj-11	128	1	mb	ORG
gsrj-11	131	1	4.2	CARDINAL
gsrj-11	132	1	2010	DATE
gsrj-11	132	2	cancer.31	GPE
gsrj-11	132	3	2015	DATE
gsrj-11	136	1	one	CARDINAL
gsrj-11	136	2	16year	CARDINAL
gsrj-11	138	1	23	CARDINAL
gsrj-11	139	1	91	CARDINAL
gsrj-11	142	1	two	CARDINAL
gsrj-11	142	2	models.32	PRODUCT
gsrj-11	142	3	33	DATE
gsrj-11	144	1	two	CARDINAL
gsrj-11	146	1	gant-61	DATE
gsrj-11	147	1	gant61	ORG
gsrj-11	147	2	gant-58	DATE
gsrj-11	149	1	doses.36	GPE
gsrj-11	152	1	4.3	CARDINAL
gsrj-11	154	1	2015	DATE
gsrj-11	154	2	two	CARDINAL
gsrj-11	154	3	ptch1	PERSON
gsrj-11	155	1	ptch1	ORG
gsrj-11	157	1	secondly	ORDINAL
gsrj-11	159	1	thousands	CARDINAL
gsrj-11	159	2	activity.19	ORG
gsrj-11	160	1	92	CARDINAL
gsrj-11	161	1	third	ORDINAL
gsrj-11	168	1	two	CARDINAL
gsrj-11	170	1	second	ORDINAL
gsrj-11	172	1	trials.6	GPE
gsrj-11	174	1	ptch1	ORG
gsrj-11	175	1	gli2	PERSON
gsrj-11	181	1	93	CARDINAL
gsrj-11	181	2	georgetown scientific research	ORG
gsrj-11	181	3	5	CARDINAL
gsrj-11	182	1	first	ORDINAL
gsrj-11	183	1	150mg	QUANTITY
gsrj-11	186	1	400mg	QUANTITY
gsrj-11	191	1	gli	ORG
gsrj-11	194	1	atoh1	PERSON
gsrj-11	194	2	cxcl12	ORG
gsrj-11	194	3	cxcr4	ORG
gsrj-11	194	4	14%	PERCENT
gsrj-11	194	5	more than 95%	PERCENT
gsrj-11	195	1	94	CARDINAL
gsrj-11	202	1	6	CARDINAL
gsrj-11	202	2	glasdegib	ORG
gsrj-11	202	3	gant-61	DATE
gsrj-11	206	1	nhs	ORG
gsrj-11	206	2	dr.	PERSON
gsrj-11	206	3	tilan	PERSON
gsrj-11	207	1	1	CARDINAL
gsrj-11	208	1	huang	PERSON
gsrj-11	208	2	s. y.,	PERSON
gsrj-11	208	3	j. y.	PERSON
gsrj-11	208	4	2015	CARDINAL
gsrj-11	210	1	7(4	CARDINAL
gsrj-11	210	2	2110-2123	CARDINAL
gsrj-11	212	1	majd	PERSON
gsrj-11	212	2	n., & penas-prado	ORG
gsrj-11	212	3	m.	PERSON
gsrj-11	212	4	2019	DATE
gsrj-11	214	1	20(8	CARDINAL
gsrj-11	214	2	1-24	DATE
gsrj-11	214	3	3	CARDINAL
gsrj-11	215	1	the university of texas	ORG
gsrj-11	215	2	md anderson	PERSON
gsrj-11	218	1	4. northcott, p. a.	PERCENT
gsrj-11	218	2	i.	PERSON
gsrj-11	218	3	morrissy	GPE
gsrj-11	218	4	a. s.	PERSON
gsrj-11	218	5	weischenfeldt	PERSON
gsrj-11	218	6	j., ehrenberger	PERSON
gsrj-11	218	7	t., ... & lichter	ORG
gsrj-11	218	8	2017	CARDINAL
gsrj-11	220	1	547(7663	CARDINAL
gsrj-11	220	2	311	CARDINAL
gsrj-11	220	3	5	CARDINAL
gsrj-11	220	4	millard, n. e., & de braganca	PERSON
gsrj-11	220	5	k. c.	PERSON
gsrj-11	220	6	2016	DATE
gsrj-11	222	1	1341-1353	CARDINAL
gsrj-11	223	1	https://doi.org/0.1177/0883073815600866 6	DATE
gsrj-11	224	1	liu	PERSON
gsrj-11	224	2	x.	GPE
gsrj-11	224	3	w.	PERSON
gsrj-11	224	4	2020	DATE
gsrj-11	226	1	210	CARDINAL
gsrj-11	226	2	107516	DATE
gsrj-11	229	1	i. n.	PERSON
gsrj-11	229	2	l. t. h.	PERSON
gsrj-11	229	3	jun, n.	PERSON
gsrj-11	229	4	wijaya	PERSON
gsrj-11	229	5	y. t.	PERSON
gsrj-11	229	6	lee	GPE
gsrj-11	229	7	s., & kwon	ORG
gsrj-11	229	8	h. y.	PERSON
gsrj-11	229	9	2018	DATE
gsrj-11	231	1	7(11	CARDINAL
gsrj-11	231	2	208	CARDINAL
gsrj-11	232	1	cells7110208	ORG
gsrj-11	233	1	shimada	GPE
gsrj-11	233	2	i. s.	PERSON
gsrj-11	233	3	hwang	GPE
gsrj-11	233	4	s. h.	PERSON
gsrj-11	233	5	b. n.	PERSON
gsrj-11	233	6	wang	PERSON
gsrj-11	233	7	x.	GPE
gsrj-11	233	8	skowron	ORG
gsrj-11	233	9	kim	PERSON
gsrj-11	233	10	j.	PERSON
gsrj-11	233	11	s. (2018	ORG
gsrj-11	235	1	22(5	CARDINAL
gsrj-11	235	2	1169	CARDINAL
gsrj-11	237	1	2021	CARDINAL
gsrj-11	238	1	24776445	DATE
gsrj-11	239	1	february 4	DATE
gsrj-11	239	2	2021	DATE
gsrj-11	240	1	1	CARDINAL
gsrj-11	241	1	dlugosz, a.	PERSON
gsrj-11	241	2	agrawal	GPE
gsrj-11	241	3	s., & kirkpatrick	ORG
gsrj-11	241	4	2012	DATE
gsrj-11	243	1	11(6	CARDINAL
gsrj-11	243	2	437	CARDINAL
gsrj-11	244	1	11	CARDINAL
gsrj-11	245	1	gould	ORG
gsrj-11	245	2	s. e.	PERSON
gsrj-11	245	3	j. a.	PERSON
gsrj-11	245	4	marsters jr	PERSON
gsrj-11	245	5	j. c.	PERSON
gsrj-11	245	6	rubin	PERSON
gsrj-11	245	7	l. l.	PERSON
gsrj-11	245	8	f. j.	PERSON
gsrj-11	245	9	r. l.	PERSON
gsrj-11	245	10	2014	DATE
gsrj-11	247	1	discovery	PRODUCT
gsrj-11	247	2	9(8	CARDINAL
gsrj-11	247	3	969	CARDINAL
gsrj-11	248	1	6 12	CARDINAL
gsrj-11	248	2	atwood, s. x.	ORG
gsrj-11	248	3	k. y.	PERSON
gsrj-11	248	4	whitson	PERSON
gsrj-11	248	5	r. j.	PERSON
gsrj-11	248	6	li	PERSON
gsrj-11	248	7	j. r.	PERSON
gsrj-11	248	8	kim	PERSON
gsrj-11	248	9	j. y.	PERSON
gsrj-11	248	10	2015	CARDINAL
gsrj-11	250	1	342	CARDINAL
gsrj-11	250	2	13	CARDINAL
gsrj-11	251	1	m. j.	PERSON
gsrj-11	251	2	li	PERSON
gsrj-11	251	3	q.	PERSON
gsrj-11	251	4	shavnya, a.	PERSON
gsrj-11	251	5	borzillo	ORG
gsrj-11	251	6	g. v.	PERSON
gsrj-11	251	7	boyden	GPE
gsrj-11	251	8	t. l.	PERSON
gsrj-11	251	9	jones	PERSON
gsrj-11	251	10	c. s.	PERSON
gsrj-11	251	11	g. t.	PERSON
gsrj-11	251	12	2012	DATE
gsrj-11	253	1	acs medicinal chemistry letters	ORG
gsrj-11	253	2	3(2	CARDINAL
gsrj-11	253	3	106	CARDINAL
gsrj-11	254	1	14	CARDINAL
gsrj-11	255	1	fukushima	GPE
gsrj-11	255	2	n.	ORG
gsrj-11	255	3	minami	PERSON
gsrj-11	255	4	kakiuchi	PERSON
gsrj-11	255	5	s.	PERSON
gsrj-11	255	6	kuwatsuka	ORG
gsrj-11	255	7	hayakawa	ORG
gsrj-11	255	8	f., jamieson	PERSON
gsrj-11	255	9	t.	GPE
gsrj-11	255	10	2016	CARDINAL
gsrj-11	257	1	107(10	CARDINAL
gsrj-11	257	2	1422-1429	CARDINAL
gsrj-11	258	1	15	CARDINAL
gsrj-11	259	1	wolska	PERSON
gsrj-11	259	2	a., & robak	ORG
gsrj-11	259	3	2019	DATE
gsrj-11	260	1	glasdegib	PERSON
gsrj-11	261	1	3219-3232	QUANTITY
gsrj-11	261	2	16	DATE
gsrj-11	262	1	li	PERSON
gsrj-11	262	2	q., & day	ORG
gsrj-11	262	3	b. w.	PERSON
gsrj-11	262	4	2019	DATE
gsrj-11	264	1	acta neuropathologica communications	PERSON
gsrj-11	264	2	7(1	DATE
gsrj-11	264	3	1-8	DATE
gsrj-11	266	1	p. m.	PERSON
gsrj-11	266	2	rudin	PERSON
gsrj-11	266	3	c. m.	PERSON
gsrj-11	266	4	reddy	PERSON
gsrj-11	266	5	j. c.	PERSON
gsrj-11	266	6	r.	NORP
gsrj-11	266	7	weiss	GPE
gsrj-11	266	8	g. j.	PERSON
gsrj-11	266	9	borad	PERSON
gsrj-11	266	10	m. j.	PERSON
gsrj-11	266	11	von hoff	PERSON
gsrj-11	266	12	d. d.	NORP
gsrj-11	266	13	2011	DATE
gsrj-11	267	1	gdc-0449	DATE
gsrj-11	268	1	25022511	DATE
gsrj-11	270	1	1	CARDINAL
gsrj-11	271	1	gajjar	ORG
gsrj-11	271	2	a.	GPE
gsrj-11	271	3	stewart	PERSON
gsrj-11	271	4	c. f., ellison	PERSON
gsrj-11	271	5	d. w.	PERSON
gsrj-11	271	6	s.	GPE
gsrj-11	271	7	kun	ORG
gsrj-11	271	8	l. e.	PERSON
gsrj-11	271	9	r. j.	PERSON
gsrj-11	271	10	... & curran	ORG
gsrj-11	271	11	t.	GPE
gsrj-11	271	12	2013	DATE
gsrj-11	273	1	19(22	CARDINAL
gsrj-11	273	2	6305-6312	DATE
gsrj-11	276	1	robinson	PERSON
gsrj-11	276	2	g. w.	PERSON
gsrj-11	276	3	orr	GPE
gsrj-11	276	4	b. a.	PERSON
gsrj-11	276	5	wu	PERSON
gsrj-11	276	6	g.	PERSON
gsrj-11	276	7	s.	GPE
gsrj-11	276	8	lin	GPE
gsrj-11	276	9	t., qaddoumi	GPE
gsrj-11	276	10	i.	PERSON
gsrj-11	276	11	a.	PERSON
gsrj-11	276	12	2015	CARDINAL
gsrj-11	278	1	33(24	CARDINAL
gsrj-11	278	2	91	CARDINAL
gsrj-11	278	3	2	CARDINAL
gsrj-11	279	1	rodon	PERSON
gsrj-11	279	2	j.	PERSON
gsrj-11	279	3	h. a.	PERSON
gsrj-11	279	4	thomas, a. l.	PERSON
gsrj-11	279	5	stoller	PERSON
gsrj-11	279	6	r. g.	PERSON
gsrj-11	279	7	c. p.	PERSON
gsrj-11	279	8	j., ... & mita	ORG
gsrj-11	279	9	a. c.	PERSON
gsrj-11	279	10	2014	DATE
gsrj-11	280	1	first	ORDINAL
gsrj-11	281	1	20(7	GPE
gsrj-11	281	2	1900-1909	DATE
gsrj-11	282	1	96	CARDINAL
gsrj-11	282	2	georgetown scientific research	ORG
gsrj-11	282	3	21	CARDINAL
gsrj-11	283	1	kieran	PERSON
gsrj-11	283	2	m. w.	PERSON
gsrj-11	283	3	chisholm	ORG
gsrj-11	283	4	j., casanova, m., brandes, a. a.	PERSON
gsrj-11	283	5	aerts, i.	ORG
gsrj-11	283	6	bouffet	PERSON
gsrj-11	283	7	b.	PERSON
gsrj-11	283	8	2017	CARDINAL
gsrj-11	285	1	19(11	DATE
gsrj-11	285	2	1542-1552	CARDINAL
gsrj-11	286	1	https://doi.org/10.1093/neuonc/nox109	GPE
gsrj-11	287	1	22	CARDINAL
gsrj-11	288	1	wang	PERSON
gsrj-11	288	2	wu	PERSON
gsrj-11	288	3	h.	PERSON
gsrj-11	288	4	e.	PERSON
gsrj-11	288	5	han	NORP
gsrj-11	288	6	g. w.	PERSON
gsrj-11	288	7	huang	PERSON
gsrj-11	288	8	r. c.	PERSON
gsrj-11	288	9	2014	DATE
gsrj-11	290	1	5(1	CARDINAL
gsrj-11	290	2	1-11	CARDINAL
gsrj-11	292	1	23	CARDINAL
gsrj-11	292	2	petrirena	PERSON
gsrj-11	292	3	g. j.	PERSON
gsrj-11	292	4	j.	GPE
gsrj-11	292	5	sala	GPE
gsrj-11	292	6	q.	PERSON
gsrj-11	292	7	d.	NORP
gsrj-11	292	8	e.	PERSON
gsrj-11	292	9	2018	DATE
gsrj-11	294	1	9(11	CARDINAL
gsrj-11	294	2	10175	DATE
gsrj-11	296	1	24	CARDINAL
gsrj-11	297	1	lin	PERSON
gsrj-11	297	2	z.	PERSON
gsrj-11	297	3	li	PERSON
gsrj-11	297	4	s.	PERSON
gsrj-11	297	5	m., ma	PERSON
gsrj-11	297	6	l. y. s.	PERSON
gsrj-11	297	7	hu	PERSON
gsrj-11	297	8	l.	PERSON
gsrj-11	297	9	2016	DATE
gsrj-11	299	1	142(12	CARDINAL
gsrj-11	299	2	2469-2478	DATE
gsrj-11	301	1	25	CARDINAL
gsrj-11	302	1	pan, s., wu	PERSON
gsrj-11	302	2	x.	GPE
gsrj-11	302	3	jiang	GPE
gsrj-11	302	4	j., gao	PERSON
gsrj-11	302	5	w.	PERSON
gsrj-11	302	6	wan	PERSON
gsrj-11	302	7	cheng	PERSON
gsrj-11	302	8	d.	NORP
gsrj-11	302	9	... & dorsch	ORG
gsrj-11	302	10	m. (	PERSON
gsrj-11	302	11	2010	DATE
gsrj-11	304	1	acs medicinal chemistry letters	ORG
gsrj-11	304	2	1(3	CARDINAL
gsrj-11	304	3	130	CARDINAL
gsrj-11	305	1	26	CARDINAL
gsrj-11	306	1	jones	PERSON
gsrj-11	306	2	d. t.	PERSON
gsrj-11	306	3	jäger, n.	ORG
gsrj-11	306	4	northcott	ORG
gsrj-11	306	5	p. a.	PERSON
gsrj-11	306	6	pugh	ORG
gsrj-11	306	7	t. j.	PERSON
gsrj-11	306	8	s. m.	PERSON
gsrj-11	306	9	2014	DATE
gsrj-11	308	1	25(3	CARDINAL
gsrj-11	308	2	393	CARDINAL
gsrj-11	310	1	2	CARDINAL
gsrj-11	311	1	lou, e., nelson	PERSON
gsrj-11	311	2	a. c.	PERSON
gsrj-11	311	3	m.	PERSON
gsrj-11	311	4	2019	DATE
gsrj-11	313	1	20(11	CARDINAL
gsrj-11	313	2	1398-1402	DATE
gsrj-11	315	1	57	CARDINAL
gsrj-11	315	2	2	CARDINAL
gsrj-11	316	1	casey	PERSON
gsrj-11	316	2	d.	NORP
gsrj-11	316	3	demko, s.	PERSON
gsrj-11	316	4	s.	PERSON
gsrj-11	316	5	zhao	PERSON
gsrj-11	316	6	chen, h.	PERSON
gsrj-11	316	7	k.	PERSON
gsrj-11	316	8	r.	PERSON
gsrj-11	316	9	2017	CARDINAL
gsrj-11	317	1	fda	ORG
gsrj-11	318	1	2377-2381	CARDINAL
gsrj-11	319	1	2	CARDINAL
gsrj-11	320	1	k. y.	PERSON
gsrj-11	320	2	a. e., & chang	PERSON
gsrj-11	320	3	a. l. s.	PERSON
gsrj-11	320	4	2016	DATE
gsrj-11	322	1	22(6	CARDINAL
gsrj-11	322	2	1325-1329	CARDINAL
gsrj-11	323	1	3 .	TIME
gsrj-11	324	1	liu	PERSON
gsrj-11	324	2	d.	NORP
gsrj-11	324	3	yang	GPE
gsrj-11	324	4	j.	PERSON
gsrj-11	324	5	wang	PERSON
gsrj-11	324	6	j., liu	PERSON
gsrj-11	324	7	x.	GPE
gsrj-11	324	8	huang	PERSON
gsrj-11	324	9	w.	PERSON
gsrj-11	324	10	a.	PERSON
gsrj-11	324	11	2016	CARDINAL
gsrj-11	325	1	2-(2	CARDINAL
gsrj-11	325	2	5	CARDINAL
gsrj-11	325	3	6	CARDINAL
gsrj-11	325	4	7	DATE
gsrj-11	325	5	8tetrahydroquinolin-8	CARDINAL
gsrj-11	326	1	journal of medicinal chemistry	ORG
gsrj-11	326	2	11050-11068	DATE
gsrj-11	328	1	7. 31	DATE
gsrj-11	329	1	peukert, s., & miller!moslin	ORG
gsrj-11	329	2	k.	PERSON
gsrj-11	329	3	2010	DATE
gsrj-11	332	1	discovery	PRODUCT
gsrj-11	332	2	5(4	CARDINAL
gsrj-11	332	3	500-512	CARDINAL
gsrj-11	333	1	10.1002	CARDINAL
gsrj-11	333	2	32	CARDINAL
gsrj-11	334	1	mori	PERSON
gsrj-11	334	2	m.	PERSON
gsrj-11	334	3	a.	GPE
gsrj-11	334	4	s., & botta	ORG
gsrj-11	334	5	2016	DATE
gsrj-11	335	1	one hundred	CARDINAL
gsrj-11	336	1	1658-1681	CARDINAL
gsrj-11	337	1	10.2174/1381612822666160112130157	CARDINAL
gsrj-11	338	1	97	CARDINAL
gsrj-11	338	2	georgetown scientific research	ORG
gsrj-11	338	3	33	CARDINAL
gsrj-11	339	1	h.	PERSON
gsrj-11	339	2	j. m.	PERSON
gsrj-11	339	3	t.	GPE
gsrj-11	339	4	2008	DATE
gsrj-11	341	1	13(3	CARDINAL
gsrj-11	341	2	249	CARDINAL
gsrj-11	343	1	romer	PERSON
gsrj-11	343	2	j. t.	PERSON
gsrj-11	343	3	h.	PERSON
gsrj-11	343	4	magdaleno	GPE
gsrj-11	343	5	s.	GPE
gsrj-11	343	6	sasai	GPE
gsrj-11	343	7	k.	PERSON
gsrj-11	343	8	... & curran	ORG
gsrj-11	343	9	t.	GPE
gsrj-11	343	10	2004	DATE
gsrj-11	346	1	6(3	CARDINAL
gsrj-11	346	2	229-240	CARDINAL
gsrj-11	348	1	35	DATE
gsrj-11	349	1	jha	PERSON
gsrj-11	349	2	b. k.	PERSON
gsrj-11	349	3	t., & houghton	ORG
gsrj-11	349	4	j. a.	PERSON
gsrj-11	349	5	2014	DATE
gsrj-11	350	1	gant61	ORG
gsrj-11	351	1	5(12	CARDINAL
gsrj-11	351	2	4492	DATE
gsrj-11	353	1	wang, f., jiang, h., deng, y., yu	PERSON
gsrj-11	353	2	j., zhan	PERSON
gsrj-11	353	3	m., zhao	PERSON
gsrj-11	353	4	2018	DATE
gsrj-11	355	1	bioorganic & medicinal chemistry letters	ORG
gsrj-11	355	2	2399-2402	CARDINAL
gsrj-11	357	1	3	CARDINAL
gsrj-11	357	2	j. v.	PERSON
gsrj-11	357	3	kaidi, a., & jackson	ORG
gsrj-11	357	4	s. p.	PERSON
gsrj-11	357	5	2012	DATE
gsrj-11	359	1	663-670	CARDINAL
gsrj-11	360	1	3	CARDINAL
gsrj-11	361	1	wetmore	PERSON
gsrj-11	361	2	d. e.	PERSON
gsrj-11	361	3	t.	GPE
gsrj-11	361	4	2001	DATE
gsrj-11	363	1	61(2	CARDINAL
gsrj-11	363	2	513	CARDINAL
gsrj-11	364	1	kim	PERSON
gsrj-11	364	2	j.	PERSON
gsrj-11	364	3	malhotra, a.	PERSON
gsrj-11	364	4	liu	PERSON
gsrj-11	364	5	j., ahn	PERSON
gsrj-11	364	6	s. i.	PERSON
gsrj-11	364	7	sei	PERSON
gsrj-11	364	8	kim	PERSON
gsrj-11	364	9	2020	DATE
gsrj-11	366	1	the national academy of sciences	ORG
gsrj-11	366	2	117(39	CARDINAL
gsrj-11	366	3	24205-24212	DATE
gsrj-11	367	1	98	CARDINAL
gsrj-11	367	2	the united states	GPE
gsrj-11	367	3	covid-19	PERSON
gsrj-11	367	4	new mexico	GPE
gsrj-11	367	5	utah	GPE